Google News -Search

Chinese Bone-strengthening pill (Jiangusheng Wan) promotes bone cell and chondrocyte repair

New York, Aug 27, 2018 - Recently, Dr. WANG Lulin, director of Beijing Jianxing Traditional Chinese Medicine Hospital, developed a traditional Chinese medicine mixture, Bonestrengthening pill (BSP, also called Jiangusheng Wan), which could promote blood circulation, remove blood stasis, and promote regeneration of the bone. BSP treatment can inhibit and reverse necrosis of the femoral head bone cells and cartilage cells, repair the femoral head, and promote the repair of bone and cartilage diseases. Bone and joint disease is a kind of disease of bone and chondrocyte, which comprises osteonecrosis, osteomyelitis, osteoarthritis, fibrous dysplasia of bone, osteoporosis, etc...

Femoral head necrosis is one of the typical osteoarthropathy, and patients with femoral head necrosis would be prone to be disabled. As the population ages, the incidence of bone and cartilage disease will become higher and higher, seriously endangering human health. So far there are no effective methods or drugs to promote the repair of bone and chondrocyte disease in the world. This study has solved such problem and has made a breakthrough in the treatment of osteonecrosis, as well as bone and cartilage diseases, and fill a medical gap in the treatment of major, multiple and refractory diseases in the world. The study was published in a renowned international journal, entitled Bone strengthening pill (BSP) promotes bone cell and chondrocyte repair, and the clinical and experimental study of BSP in the treatment of osteonecrosis of the femoral head.

Website: https://doi.org/10.18632/oncotarget.21226

谷歌新闻：中药健骨生丸（Jiangusheng Wan）促进骨细胞及软骨细胞修复

纽约，2018年8月27日-最近，北京健行中医院院长王璐林博士研制出一种能促进血液循环，消除血瘀，促进血液循环，促进骨与软骨细胞再生修复的中药合剂。健骨生丸（BSP，也叫Jiangusheng Wan）。能抑制和逆转股骨头骨细胞和软骨细胞的坏死，修复股骨头，促进骨和软骨疾病的修复。骨关节病是一种骨和软骨细胞疾病，包括骨坏死、骨髓炎、骨关节炎、骨纤维结构不良、骨质疏松等。

股骨头坏死是典型的骨关节病之一，股骨头坏死等骨关节疾病是高致残、危害人类健康严重的多发性疾病。随着人口老龄化，骨与关节疾病的发病率将越来越高，严重危害人类健康。到目前为止，还没有有效的方法或药物来促进骨和软骨疾病的修复。本研究解决了上述问题，在治疗骨坏死以及骨和软骨疾病方面取得了重大突破，填补了一项国际上治疗重大、多发和难治性疾病的空白。这项研究《健骨生丸（BSP）促进骨细胞和软骨细胞修复，治疗股骨头坏死的临床和实验研究》发表在著名的国际期刊上。

网站：HTTPS://DOI.Org/101863/OnCo Toal.21226